In people with Down syndrome and AD, neurons display reduced Aβ in neurons, thought to be the result of a shift in APP processing from in amino-terminally truncated intraneuronal Aβ to extracellular secretion of Aβ40/42 in AD patients [10]. This evidence concerns the gene APP and Alzheimer disease.